Ancrod in sickle-cell crisis.
D000208:Acute Disease; D000755:Anemia, Sickle Cell / Q000097:blood / Q000188:drug therapy*; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D005337:Fibrin / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D005341:Fibrinolysin / Q000032:analysis; D005342:Fibrinolysis; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D005947:Glucose / Q000627:therapeutic use; D006801:Humans; D010958:Plasminogen / Q000032:analysis; D013997:Time Factors; D014688:Venoms / Q000008:administration & dosage / Q000627:therapeutic use*
D000925:Anticoagulants; D001639:Bicarbonates; D005343:Fibrinolytic Agents; D014688:Venoms; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D005341:Fibrinolysin; D005947:Glucose